| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $239.74 | $143,842.87 | -0.2% | +12.7% | +15.6% | |
| Nov 18, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 7,975 | $45.61 | $363,752.31 | -5.9% | -31.0% | -78.5% | |
| Nov 18, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 42,604 | $20.70 | $882,110.20 | -4.5% | +38.3% | +17.4% | |
| Nov 15, 2024 | MMSI Merit Medical Systems Inc | Millner F. Ann49 | Director | Sell | 12,500 | $101.55 | $1,269,375.00 | -27.8% | +6.4% | -16.4% | |
| Nov 15, 2024 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 3,203 | $0.80 | $2,562.40 | -1.4% | +3.5% | -60.6% | |
| Nov 15, 2024 | ATR Aptargroup, Inc. | Chainey Kimberly49 | EVP And Chief Legal Officer | Sell | 964 | $168.83 | $162,752.41 | -10.9% | -14.2% | -28.8% | |
| Nov 15, 2024 | DXCM Dexcom Inc | Sylvain Jereme M65 | EVP, Chief Financal Officer | Sell | 3,500 | $75.51 | $264,285.00 | -4.2% | +10.8% | -23.5% | |
| Nov 15, 2024 | OM Outset Medical, Inc. | Ahmed Nabeel84 | Chief Financial Officer | Sell | 4,221 | $0.80 | $3,376.80 | -1.3% | +3.5% | -60.6% | |
| Nov 15, 2024 | OM Outset Medical, Inc. | Nash Marc83 | SVP Operations And R&D | Sell | 1,375 | $0.80 | $1,100.00 | -0.6% | +3.5% | -60.6% | |
| Nov 15, 2024 | TNDM Tandem Diabetes Care Inc | Novara Mark David | EVP &Chief Commercial Officer | Buy | 532 | $23.24 | $12,363.68 | New | +19.3% | -31.9% | |
| Nov 15, 2024 | LMAT Lemaitre Vascular Inc | Ross Bridget A | Director | Sell | 3,750 | $101.47 | $380,512.50 | -62.2% | -4.9% | -13.3% | |
| Nov 15, 2024 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 5,645 | $0.80 | $4,516.00 | -0.6% | +3.5% | -60.6% | |
| Nov 15, 2024 | SYK Stryker Corp | Stiles Spencer S | Group President | Sell | 514 | $391.16 | $201,056.24 | -1.0% | -0.4% | -7.1% | |
| Nov 13, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 7,736 | $0.70 | $5,422.94 | - | +18.1% | +17.2% | |
| Nov 13, 2024 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 26,420 | $94.08 | $2,485,572.71 | -2.7% | -28.5% | -67.0% | |
| Nov 13, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 5,000 | $65.57 | $327,843.00 | -9.6% | +6.6% | +29.4% | |
| Nov 13, 2024 | LMAT Lemaitre Vascular Inc | Shadan Martha | Director | Sell | 1,466 | $103.37 | $151,547.27 | -32.8% | -5.5% | -12.6% | |
| Nov 13, 2024 | AHCO Adapthealth Corp. | Wolf Dale B46 | Director | Sell | 7,000 | $10.80 | $75,600.00 | -8.5% | -13.3% | -12.0% | |
| Nov 13, 2024 | VMD Viemed Healthcare, Inc. | Dobbs Randy E. | Director | Sell | 36,261 | $9.28 | $336,502.08 | -25.2% | -13.8% | -29.9% | |
| Nov 13, 2024 | UFPT Ufp Technologies Inc | Bailly R Jeffrey55 | CEO | Sell | 15,021 | $346.34 | $5,202,302.03 | -4.2% | -16.8% | -25.6% | |
| Nov 13, 2024 | RXST Rxsight, Inc. | Corley Jesse Anderson | Director | Buy | 22,476 | $45.14 | $1,014,570.10 | +2.3% | -27.9% | -78.5% | |
| Nov 13, 2024 | VMD Viemed Healthcare, Inc. | Kaushal Nitin82 | Director | Sell | 60,000 | $9.52 | $571,200.00 | -19.1% | -13.8% | -29.9% | |
| Nov 12, 2024 | QTIH Qt Imaging Holdings, Inc. | Weiner Zeev | Director | Buy | 85,616 | $0.58 | $49,999.74 | New | - | - | |
| Nov 12, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 66 | $26.34 | $1,738.44 | - | -2.2% | -2.2% | |
| Nov 12, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 91 | $26.34 | $2,396.94 | - | -2.2% | -2.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.